£490.00

It has never been this cheap. We have no record of a lower price.

£490 today · cheaper than every other day in the last 3 months

US Targeted Therapy Liver Cancer Drug Outlook 2023-2028

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 20 days · 20 data points (no recent data)

Historical
Generating forecast…
£490.00 £465.50 £475.30 £485.10 £494.90 £504.70 £514.50 03 August 2026 07 August 2026 12 August 2026 17 August 2026 22 August 2026
View at Amazon ↗

Price data last checked 71 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 20 days • 1 price levels

Days at Price
20 days 0 5 10 15 20 £490 Days at Price

Price Analysis

Most common price: £490 (20 days, 100.0%)

Price range: £490 - £490

Price levels: 1 different prices over 20 days

Description

This comprehensive study provides a detailed outlook for targeted therapy liver cancer drugs across the United States from 2023 to 2028. The report focuses on latent demand, also known as potential industry earnings (P.I.E.), providing estimates in millions of U.S. dollars. By analyzing 10,833 specific zip codes, the data offers granular insights into market opportunities at a local level. Users can access comparative benchmarks that show the percent share each zip code holds relative to its state and the nation as a whole. This statistical approach helps professionals quickly gauge specific geographic areas against others. These insights are designed to assist with strategic planning for sales force deployment and distribution logistics within the pharmaceutical industry.

Key Features

Provides latent demand estimates in millions of U.S. dollars for targeted therapy liver cancer drugs.

Includes detailed potential industry earnings (P.I.E.) data across 10,833 US zip codes.

Offers comparative benchmarks by reporting each zip code's percent share of its state and the entire United States.

Supports sales force and distribution strategies through granular geographic statistical analysis.

Covers a specific market outlook period spanning from 2023 through 2028.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
09 January 2023
Listed Since
27 January 2023

Similar Products You Might Like

The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in China
99% match

The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in China

£495.00 20 Aug 2026
The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in the United States
98% match

The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in the United States

£520.00 21 Aug 2026
The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in India
98% match

The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in India

£515.00 22 Aug 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics for US Zip Codes
97% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics for US Zip Codes

£490.00 02 Oct 2026
The 2016-2021 Outlook for Liver Cancer Drugs in Japan
97% match

The 2016-2021 Outlook for Liver Cancer Drugs in Japan

£595.00 27 Aug 2026
Cancer Therapies in Asia 2016-2021 Outlook - Econometric Study
97% match

Cancer Therapies in Asia 2016-2021 Outlook - Econometric Study

£425.00 22 Aug 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in China
97% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in China

£495.00 23 Sep 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in Japan
97% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in Japan

£495.00 02 Oct 2026
US Cancer Diagnostics Lab Test Outlook 2023-2028 Study
97% match

US Cancer Diagnostics Lab Test Outlook 2023-2028 Study

£490.00 24 Aug 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in China
97% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in China

£495.00 01 Oct 2026
US Cancer Screening Outlook 2023-2028 - Zip Code Study
97% match

US Cancer Screening Outlook 2023-2028 - Zip Code Study

£490.00 24 Aug 2026
Cancer Therapy Outlook 2016-2021 - North America & Caribbean
97% match

Cancer Therapy Outlook 2016-2021 - North America & Caribbean

£425.00 22 Aug 2026
The 2023-2028 Outlook for Cancer Testing-Screening for US Zip Codes
97% match

The 2023-2028 Outlook for Cancer Testing-Screening for US Zip Codes

£490.00 01 Oct 2026
The 2025-2030 World Outlook for Liver Cancer Diagnostics
97% match

The 2025-2030 World Outlook for Liver Cancer Diagnostics

Price unavailable
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Europe
97% match

The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Europe

£325.00 27 Sep 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States
97% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States

£520.00 21 Aug 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in Japan
97% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in Japan

£495.00 26 Sep 2026
NSCLC Therapeutics Outlook in Asia (2013-2018) Study
97% match

NSCLC Therapeutics Outlook in Asia (2013-2018) Study

£325.00 27 Aug 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in India
97% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in India

£515.00 21 Aug 2026
The 2023-2028 Outlook for Cancer Supportive Care in the United States
97% match

The 2023-2028 Outlook for Cancer Supportive Care in the United States

£520.00 22 Aug 2026
The 2025-2030 World Outlook for Cancer Therapies
97% match

The 2025-2030 World Outlook for Cancer Therapies

Price unavailable
Natural Killer Cell Therapeutics US Zip Code Outlook 2023-2028
97% match

Natural Killer Cell Therapeutics US Zip Code Outlook 2023-2028

£490.00 21 Aug 2026
Non-Small Cell Lung Cancer Outlook 2023-2028 US Zip Codes
96% match

Non-Small Cell Lung Cancer Outlook 2023-2028 US Zip Codes

£490.00 26 Aug 2026
Uterine Cancer Therapeutics and Diagnostics Outlook 2023-2028
96% match

Uterine Cancer Therapeutics and Diagnostics Outlook 2023-2028

£490.00 21 Aug 2026